GOF mutations in PI3K signaling in APDS patients gave us the opportunity to compare the direct effects of a genetically defined overactive PI3Kδ with the observed signaling alterations in CVID. This evidence concerns the gene PIK3CD and activated PI3K-delta syndrome.